Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Ticlopidine Hydrochloride Tablets

Approval Number

国药准字H20094082

Company成都恒瑞制药有限公司

Registration Date

April 24, 2024

Drug Information

Generic Name

盐酸噻氯匹定片

Brand Name

思羽

Dosage Form

片剂

Strength

0.25g

Drug Type

化学药品

Registration Date

April 24, 2024

Company Information

Applicant Company

Company Name成都恒瑞制药有限公司

Company Address

成都高新区西部园区百草路18号

Manufacturing Company

Company Name成都恒瑞制药有限公司

Company Address

成都高新区西部园区百草路18号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy